Single-cell RNA sequencing analysis reveals a lack of CXCL13<sup>+</sup> T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy.

Cancer Immunol Immunother · 2025 · PMC12137842 · PMID 40464813

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

We similarly identified these two cell populations and observed that the CXCL13 + CD8 + T subset tended to decrease in proportion post-treatment, while the CXCL13 + CD4 + T subset showed an increasing trend, although neither change reached statistical significance (Fig.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Single-cell RNA sequencing analysis reveals a lack of CXCL13&lt;sup&gt;+&lt;/sup&gt; T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy.

The sentences

Single-cell RNA sequencing analysis reveals a lack of CXCL13<sup>+</sup> T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy.